A股異動 | 擬建鋰電池電解液添加劑項目 永太科技(002326.SZ)漲6%再創新高
格隆匯9月1日丨永太科技(002326.SZ)股價繼續走強,盤中曾觸及漲停價49.28元,亦再創新高,現報47.64元,漲幅6.3%,最新總市值417.6億。公司昨日公吿稱,全資子公司內蒙古永太計劃使用自籌資金投資建設年產25000噸VC和5000噸FEC等項目,項目總投資為4.5億元人民幣,項目滿產後年新增收入45億元,年新增淨利潤61401.59萬元,税後財務內部收益率63.34%,税後投資回收期(含建設期)為3.49年。VC和FEC是生產鋰電池電解液的重要添加劑。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.